Phase 1 Muscular Dystrophy Trial, Recruiting (NCT06224660)

Phase 1 Muscular Dystrophy Trial, Recruiting NCT06224660 Sponsor: Sardocor Corp. Condition: Muscular Dystrophy

Printed from Voxsanity (voxsanity.com.au) — NCT06224660 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Muscular Dystrophy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Duchenne Muscular Dystrophy (DMD), confirmed by a genetic test
You have a type of heart disease (cardiomyopathy) where scarring has been found in at least 3 out of 16 sections of the heart's main pumping chamber
Your heart is pumping less than 40% of its blood with each beat, which is lower than normal
You have been on a stable, personalised plan of heart medications and steroid treatment for at least 12 months before joining the trial
You are willing and able to give your agreement (consent) to take part in the trial

Who may not be able to join:

Your blood pressure is too high or too low (abnormal)
Your liver test results are raised for reasons not related to DMD
Your kidneys may not be filtering properly, based on a specific blood marker called Cystatin C being 1.2 mg/L or higher (confirm with trial site)
You have a low level of platelets in your blood, which help with clotting
You have anaemia, meaning your red blood cell levels are too low
Your lungs are not working well enough to meet the trial's requirements (confirm with trial site for specific details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +1-617-880-7616

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06224660

Sponsor: Sardocor Corp.

Phase: Phase 1

Status: Recruiting

Condition: Muscular Dystrophy

Trial contact: +1-617-880-7616

More information: https://clinicaltrials.gov/study/NCT06224660

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Duchenne Muscular Dystrophy (DMD), confirmed by a genetic test
You have a type of heart disease (cardiomyopathy) where scarring has been found in at least 3 out of 16 sections of the heart's main pumping chamber
Your heart is pumping less than 40% of its blood with each beat, which is lower than normal
You have been on a stable, personalised plan of heart medications and steroid treatment for at least 12 months before joining the trial
You are willing and able to give your agreement (consent) to take part in the trial

Who may not be able to join:

Your blood pressure is too high or too low (abnormal)
Your liver test results are raised for reasons not related to DMD
Your kidneys may not be filtering properly, based on a specific blood marker called Cystatin C being 1.2 mg/L or higher (confirm with trial site)
You have a low level of platelets in your blood, which help with clotting
You have anaemia, meaning your red blood cell levels are too low
Your lungs are not working well enough to meet the trial's requirements (confirm with trial site for specific details)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

Sardocor Corp.

Registry

ClinicalTrials.gov

Start date

2 October 2024

Est. completion

1 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of all-cause mortality; Rate and severity of related treatment-emergent adverse events; Rate and severity of all treatment-emergent adverse events; Rate of cell-mediated immune reaction

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov